Verastem Inc banner

Company Overview

Business Description

Sector
Health Care
Industry
Biotechnology
Headquarters
United States of America US
Employees
102
IPO date
Nov 8, 2011

Verastem is a biotechnology company focused on cancer drugs, especially medicines that target tumors driven by the RAS/MAPK signaling pathway. Its main work is to develop, test, and bring to market prescription therapies for hard-to-treat cancers, with a strong emphasis on ovarian cancer and other solid tumors. In simple terms, it is a drug maker, not a hospital or a research tools company.

The company sells its treatments through the medical system, so its main customers are oncologists, cancer centers, hospitals, and the pharmacies and payers that support patient access. Verastem makes money mainly from sales of approved drugs, and it can also earn income from collaboration, licensing, or development agreements tied to its drug pipeline. Because it is a biotech company, a big part of its value comes from whether its clinical programs lead to approved medicines that doctors can prescribe.

What makes Verastem different is its narrow focus on a specific cancer biology pathway and on combination therapies, rather than on a broad range of medicines. That gives it a specialized role in the oncology market: it tries to find patient groups that may respond better to targeted treatment and then commercialize those therapies through the standard drug distribution and reimbursement system.

Verastem Inc Investor Relations

Address
117 Kendrick Street, Suite 500
Needham, Massachusetts
United States of America

Business Segments

Cancer drug development

Verastem develops and, when it has approved medicines, helps commercialize treatments for certain cancers, especially hard-to-treat blood and solid tumors. The company also runs clinical studies to test new drug candidat...

Customers and revenue model

Management

Mr. Daniel W. Paterson

President, CEO & Director

Biography unavailable

Mr. Daniel Calkins

CFO and Principal Accounting & Financial Officer

Biography unavailable

Mr. Richard H. Aldrich M.B.A.

Founder and Consultant

Biography unavailable

Dr. Robert A. Weinberg Ph.D.

Co-Founder & Chair of Scientific Advisory Board

Biography unavailable

Dr. Michelle Dipp M.D., Ph.D.

Co-Founder

Biography unavailable

Dr. Jonathan Pachter Ph.D.

Chief Scientific Officer

Biography unavailable

Ms. Cathy Carew

Chief Organizational Effectiveness Officer

Biography unavailable

Mr. Nate Sanburn

Chief Business Officer

Biography unavailable

Mr. Michael Crowther

Chief Commercial & Strategy Officer

Biography unavailable

1 / 9